Argitalpenak (11) Joaquín Manrique Escola argitalpenak

2024

  1. Hacia la estandarización de la formación de PoCUS en nefrología: el momento es ahora

    Nefrologia, Vol. 44, Núm. 1, pp. 5-9

2018

  1. Reduction in mortality associated with secondary cytomegalovirus prophylaxis after solid organ transplantation

    Transplant Infectious Disease, Vol. 20, Núm. 3

  2. Unraveling new mechanisms of renal fibrosis with potential therapeutic implications

    Hypertension

2007

  1. Folic acid and B vitamins improve hyperhomocysteinemia-induced cardiovascular risk profile in renal transplant recipients [5]

    Journal of Thrombosis and Haemostasis

2005

  1. Changes in renal transplantation: Comparison between two different series

    Transplantation Proceedings

  2. Preliminary results of the effect of treatment of hyperhomocysteinemia and its relationship with inflammation, coagulation status, and endothelial function after renal transplantation

    Transplantation Proceedings

2004

  1. Complicaciones múltiples post-trasplante renal

    Nefrologia, Vol. 24, Núm. SUPPL.3, pp. 26-29

2003

  1. Autosomal-dominant polycystic kidney disease: High prevalence of graft loss for death-related malignancies and cardiovascular risk factors

    Transplantation Proceedings

  2. Treatment of hyperhomocysteinemia after renal transplantation

    Transplantation Proceedings

2002

  1. Effects of cerivastatin in dyslipemia and other cardiovascular risk factors after renal transplantation

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 401-402

  2. Reduction in blood cyclosporine concentration by Orlistat in two renal transplant patients

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 137-139